Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US...
Exchange-traded funds (ETFs) have been gaining popularity in recent years and as investors' appetite grows for these investment instruments, asset managers are converting more and...
In the current record-low interest rate environment, dividend stocks are appealing to a wide range of buy-and-hold investors. In addition to offering passive income, many regard...
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.32 | 1.32 | 1.27 | +0.065 | +5.18% | 3.74M | Sydney | |||
| 4.00 | 4.12 | 4.00 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 42.98 | 42.98 | 41.55 | +1.780 | +4.32% | 12.00M | Sydney | |||
| 4.77 | 4.77 | 4.61 | +0.130 | +2.80% | 2.25M | Sydney | |||
| 0.34 | 0.35 | 0.32 | -0.00 | -0.73% | 91.56K | Sydney | |||
| 4.63 | 4.73 | 4.55 | +0.03 | +0.65% | 922.59K | Sydney | |||
| 167.23 | 167.70 | 165.40 | +0.970 | +0.58% | 752.83K | Sydney | |||
| 2.64 | 2.65 | 2.60 | +0.02 | +0.76% | 1.69M | Sydney | |||
| 93.54 | 94.30 | 93.10 | -0.200 | -0.21% | 2.29M | Sydney | |||
| 2.56 | 2.61 | 2.53 | -0.01 | -0.39% | 503.55K | Sydney | |||
| 0.83 | 0.85 | 0.81 | -0.030 | -3.49% | 8.78M | Sydney | |||
| 0.715 | 0.73 | 0.715 | -0.010 | -1.38% | 88.62K | Sydney | |||
| 18.25 | 18.59 | 18.20 | -0.20 | -1.08% | 420.65K | Sydney | |||
| 0.83 | 0.875 | 0.82 | -0.035 | -4.05% | 20.00M | Sydney | |||
| 0.055 | 0.058 | 0.055 | -0.002 | -3.51% | 1.30M | Sydney |